“Médecins Sans Frontières (MSF) has warned the Global Fund to Fight AIDS, Tuberculosis and Malaria of the consequences of spearheading a new pricing initiative that could result in middle-income countries paying significantly higher prices for medicines to combat diseases, including HIV and tuberculosis,” an MSF news article states. “The Global Fund needs to reconsider its support for tiered pricing — people with HIV and TB can’t afford to pay a premium on the price of life-saving drugs,” Sharonann Lynch, HIV/TB policy adviser for MSF’s Access Campaign, said, adding, “Action is needed to improve access to drugs in middle-income countries, but the proposed approach of the Global Fund is not the answer and would ultimately only worsen the situation,” according to the article (12/2).